T-cell responses to neurofilament light protein are part of the normal immune repertoire

International Immunology

Volumn 21, Issue 4, 2009, Pages 433-441

  Huizinga, Ruth ^a,b   Hintzen, Rogier Q ^b   Assink, Karin ^b   Van Meurs, Marjan ^b   Amor, Sandra ^c,d  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Autoimmunity; Axonal damage; Multiple sclerosis; Neurodegeneration; Neuronal antigens

Indexed keywords

AUTOANTIBODY; BETA INTERFERON; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD3 ANTIGEN; CD4 ANTIGEN; CD45RO ANTIGEN; CYTOSKELETON PROTEIN; GAMMA INTERFERON; GLATIRAMER; INTERLEUKIN 12P70; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; METHYLPREDNISOLONE; MYELIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NEUROFILAMENT PROTEIN; ROQUINIMEX; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; BRAIN ATROPHY; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MALE; MULTIPLE SCLEROSIS; NERVE CELL DEGENERATION; NERVE CELL LESION; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INDUCTION; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADULT; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-4; MALE; MICE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN-ASSOCIATED GLYCOPROTEIN; NEUROFILAMENT PROTEINS; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 63649151861     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxp011     Document Type: Article

References (47)

1. Kuhlmann, T., Lingfeld, G., Bitsch, A., Schuchardt, J. and Bruck, W. 2002. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125:2202.
2. Trapp, B. D., Ransohoff, R. and Rudick, R. 1999. Axonal pathology in multiple sclerosis: Relationship to neurologic disability. Curr. Opin. Neurol. 12:295.
3. DeVries, G. H. 2004. Cryptic axonal antigens and axonal loss in multiple sclerosis. Neurochem. Res. 29:1999.
4. Mathey, E. K., Derfuss, T., Storch, M. K. et al. 2007. Neurofascin as a novel target for autoantibody-mediated axonal injury. J. Exp. Med. 204:2363.
5. Newcombe, J., Gahan, S. and Cuzner, M. L. 1985. Serum antibodies against central nervous system proteins in human demyelinating disease. Clin. Exp. Immunol. 59:383.
6. Terryberry, J. W., Thor, G. and Peter, J. B. 1998. Autoantibodies in neurodegenerative diseases: Antigen-specific frequencies and intrathecal analysis. Neurobiol. Aging 19:205.
7. Bartos, A., Fialova, L., Soukupova, J., Kukal, J., Malbohan, I. and Pit'ha, J. 2007. Elevated intrathecal antibodies against the medium neurofilament subunit in multiple sclerosis. J. Neurol. 254:20.
8. Rawes, J. A., Calabrese, V. P., Khan, O. A. and DeVries, G. H. 1997. Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases. Mult. Scler. 3:363.
9. Lily, O., Palace, J. and Vincent, A. 2004. Serum autoantibodies to cell surface determinants in multiple sclerosis: A flow cytometric study. Brain 127:269.
10. Silber, E., Semra, Y. K., Gregson, N. A. and Sharief, M. K. 2002. Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit. Neurology 58:1372.
11. Ehling, R., Lutterotti, A., Wanschitz, J. et al. 2004. Increased frequencies of serum antibodies to neurofilament light in patients with primary chronic progressive multiple sclerosis. Mult. Scler. 10:601.
12. Eikelenboom, M. J., Petzold, A., Lazeron, R. H. et al. 2003. Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy. Neurology 60:219.
13. Huizinga, R., Heijmans, N., Schubert, P. et al. 2007. Immunization with neurofilament light protein induces spastic paresis and axonal degeneration in Biozzi ABH mice. J. Neuropathol. Exp. Neurol. 66:295.
14. Huizinga, R., Linington, C. and Amor, S. 2008. Resistance is futile: antineuronal autoimmunity in multiple sclerosis. Trends Immunol. 29:54.
15. Hoftberger, R., Aboul-Enein, F., Brueck, W. et al. 2004. Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathol. 14:43.
16. Forooghian, F., Cheung, R. K., Smith, W. C., O'Connor, P. and Dosch, H. M. 2007. Enolase and arrestin are novel nonmyelin autoantigens in multiple sclerosis. J. Clin. Immunol. 27:388.
17. Pender, M. P., Csurhes, P. A., Wolfe, N. P. et al. 2003. Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis. J. Clin. Neurosci. 10:63.
18. Poser, C. M., Paty, D. W., Scheinberg, L. et al. 1983. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann. Neurol. 13:227.
19. Smith, P. A., Heijmans, N., Ouwerling, B. et al. 2005. Native myelin oligodendrocyte glycoprotein promotes severe chronic neurological disease and demyelination in Biozzi ABH mice. Eur. J. Immunol. 35:1311.
20. Heins, S., Wong, P. C., Muller, S., Goldie, K., Cleveland, D. W. and Aebi, U. 1993. The rod domain of NF-L determines neurofilament architecture, whereas the end domains specify filament assembly and network formation. J. Cell Biol. 123:1517.
21. Sun, J., Link, H., Olsson, T. et al. 1991. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J. Immunol. 146:1490.
22. Diaz-Villoslada, P., Shih, A., Shao, L., Genain, C. P. and Hauser, S. L. 1999. Autoreactivity to myelin antigens: Myelin/oligodendrocyte glycoprotein is a prevalent autoantigen. J. Neuroimmunol. 99:36.
23. Kerlero de Rosbo, N., Milo, R., Lees, M. B., Burger, D., Bernard, C. C. and Ben-Nun, A. 1993. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J. Clin. Invest. 92:2602.
24. Goebels, N., Hofstetter, H., Schmidt, S., Brunner, C., Wekerle, H. and Hohlfeld, R. 2000. Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: Epitope spreading versus clonal persistence. Brain 123:508.
25. van Noort, J. M., van Sechel, A. C., Bajramovic, J. J. et al. 1995. The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis. Nature 375:798.
26. Martin, R., Jaraquemada, D., Flerlage, M. et al. 1990. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J. Immunol. 145:540.
27. Hellings, N., Baree, M., Verhoeven, C. et al. 2001. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls. J. Neurosci. Res. 63:290.
28. Zafranskaya, M., Oschmann, P., Engel, R. et al. 2007. Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis. Immunology 121:29.
29. Weissert, R., Kuhle, J., de Graaf, K. L. et al. 2002. High immunogenicity of intracellular myelin oligodendrocyte glycoprotein epitopes. J. Immunol. 169:548.
30. Tejada-Simon, M. V., Zang, Y. C., Yang, D. et al. 2000. Aberrant T cell responses to myelin antigens during clinical exacerbation in patients with multiple sclerosis. Int. Immunol. 12:1641.
31. Magram, J., Connaughton, S. E., Warrier, R. R. et al. 1996. IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 4:471.
32. De Vos, A. F., van Meurs, M., Brok, H. P. et al. 2002. Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs. J. Immunol. 169:5415.
33. Semra, Y. K., Seidi, O. A. and Sharief, M. K. 2002. Heightened intrathecal release of axonal cytoskeletal proteins in multiple sclerosis is associated with progressive disease and clinical disability. J. Neuroimmunol. 122:132.
34. Norgren, N., Rosengren, L. and Stigbrand, T. 2003. Elevated neurofilament levels in neurological diseases. Brain Res. 987:25.
35. Skoda, D., Kranda, K., Bojar, M. et al. 2006. Antibody formation against beta-tubulin class III in response to brain trauma. Brain Res. Bull. 68:213.
36. Rudehill, S., Muhallab, S., Wennersten, A. et al. 2006. Autoreactive antibodies against neurons and basal lamina found in serum following experimental brain contusion in rats. Acta. Neurochir. (Wien). 148:199; discussion 205.
37. Sommer, C., Weishaupt, A., Brinkhoff, J. et al. 2005. Paraneoplastic stiff-person syndrome: Passive transfer to rats by means of IgG antibodies to amphiphysin. Lancet 365:1406.
38. Halstead, S. K., O'Hanlon, G. M., Humphreys, P. D. et al. 2004. Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy. Brain 127:2109.
39. Giuliani, F., Goodyer, C. G., Antel, J. P. and Yong, V. W. 2003. Vulnerability of human neurons to T cell-mediated cytotoxicity. J. Immunol. 171:368.
40. Zhu, Y., Antony, J., Liu, S. et al. 2006. CD8+ lymphocyte-mediated injury of dorsal root ganglion neurons during lentivirus infection: CD154-dependent cell contact neurotoxicity. J. Neurosci. 26:3396.
41. Bechmann, I., Mor, G., Nilsen, J., Eliza, M., Nitsch, R. and Naftolin, F. 1999. FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: Evidence for the existence of an immunological brain barrier. Glia 27:62.
42. Tian, L., Lappalainen, J., Autero, M., Hanninen, S., Rauvala, H. and Gahmberg, C. G. 2008. Shedded neuronal ICAM-5 suppresses T-cell activation. Blood 111:3615.
43. Mott, R. T., Ait-Ghezala, G., Town, T. et al. 2004. Neuronal expression of CD22: Novel mechanism for inhibiting microglial proinflammatory cytokine production. Glia 46:369.
44. Tian, L., Lappalainen, J., Autero, M., Hanninen, S., Rauvala, H. and Gahmberg, C. G. 2008. Shedded neuronal ICAM-5 suppresses T cell activation. Blood 111:3615.
45. Cardona, A. E., Pioro, E. P., Sasse, M. E. et al. 2006. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9:917.
46. Prineas, J. W. 1979. Multiple sclerosis: Presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord. Science 203:1123.
47. Serafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E. and Aloisi, F. 2004. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 14:164.